Manchester Collaborative Centre for Inflammation Research (MCCIR)

At a Glance
  • Status: Active Consortium
  • Year Launched: 2012
  • Initiating Organization: University of Manchester
  • Initiator Type: Academia
  • Disease focus:
  • Location: Europe


The Manchester Collaborative Centre for Inflammation Research (MCCIR) was established to address current priorities in inflammatory disease in an open innovation, precompetitive collaboration between academia and the pharmaceutical industry.


MCCIR’s mission is to bring together clinical, industrial, and academic scientists – and innovate at this interface or in this unique interactive environment.

The following are MCCIR characteristics:

Consortium History

2012: MCCIR established


GlaxoSmithKline, AstraZeneca, and the University of Manchester have each invested £5 million.

Sponsors & Partners



University of Manchester

Last Updated: 04/08/2016

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.